Results 91 to 100 of about 2,953 (174)

Alpha₁-fetoproteins and cystic fibrosis [PDF]

, 1976
Ramirez, Paul R.
core   +1 more source

Phosphopeptidome Profiling of Human Plasma for Hepatocellular Carcinoma Biomarker Discovery. [PDF]

J Proteome Res
Saleem S, Sajid MS, Varghese RS, Sherif ZA, Kroemer A, Ressom HW.   +5 more
europepmc   +1 more source

ALPHA-FETOPROTEIN

The Kurume Medical Journal, 1977
openaire   +2 more sources

Evaluating the GALAD Score for Detection of Hepatocellular Carcinoma in Patients With Cirrhosis. [PDF]

J Clin Gastroenterol
Vo TD, Mai SH, Lam HT.
europepmc   +1 more source

Alpha-Fetoprotein 3 [PDF]

JNCI: Journal of the National Cancer Institute, 1978
Stewart Sell, Frederick F. Becker
openaire   +1 more source

Integration of circulating biomarkers and clinical factors: construction and validation of a prediction model for lung cancer metastasis. [PDF]

BMC Pulm Med
Qi W, Li Z, Xu J, Wang T.
europepmc   +1 more source

Development and Validation of a Lectin-independent Liquid Chromatography-Tandem Mass Spectrometry Method for Serum Glycosylated Alpha-fetoprotein Analysis and Comparison with a Liquid-phase Binding Assay. [PDF]

Ann Lab Med
Kim H, Park J, Suh H, Lee S, Park Y, Yang WS, Minn D, Kim SS, Cheong JY, Baek JH.   +9 more
europepmc   +1 more source

GALAD, or des-gamma-carboxy prothrombin compared with alpha-foetoprotein for the diagnosis of hepatocellular carcinoma in people with chronic liver disease. [PDF]

Cochrane Database Syst Rev
Aralica M, Nadarevic T, Colli A, Casazza G, Vranić L, Fraquelli M, Poropat G, Štimac D.   +7 more
europepmc   +1 more source

[Alpha fetoprotein].

Ginekologia polska, 1979
openaire   +3 more sources

Protein induced by vitamin K absence or antagonist II as a prognostic marker in hepatocellular carcinoma patients with normal serum alpha-fetoprotein levels. [PDF]

J Chin Med Assoc
Huang KJ, Ho CT, Lee PC, Chen SC, Liu CA, Chou SC, Lee IC, Huang YH, Luo JC, Hou MC, Wu JC, Su CW.   +11 more
europepmc   +1 more source